| Synonyms: | |
| Status: | Phase 2 |
| Entry Type: | Small molecule |
| Molecule Category: | UNKNOWN |
| UNII: | 2ND9V3MN6O |
| InChI Key | MHFMTUBUVQZIRE-WINRQGAFSA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C43H53N5O8S |
| Molecular Weight | 799.99 |
| AlogP | 4.99 |
| Hydrogen Bond Acceptor | 9.0 |
| Hydrogen Bond Donor | 2.0 |
| Number of Rotational Bond | 13.0 |
| Polar Surface Area | 164.31 |
| Molecular species | ACID |
| Aromatic Rings | 3.0 |
| Heavy Atoms | 57.0 |
| Action | Mechanism of Action | Reference |
|---|---|---|
| INHIBITOR | Hepatitis C virus serine protease, NS3/NS4A inhibitor | Other ClinicalTrials PubMed |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Hepatitis C | 2 | D006526 | ClinicalTrials |
| Hepatitis C, Chronic | 2 | D019698 | ClinicalTrials |
| Resources | Reference |
|---|---|
| CAS NUMBER | 1001667-23-7 |
| ChEMBL | CHEMBL2105750 |
| DrugBank | DB12069 |
| EPA CompTox | DTXSID00142994 |
| FDA SRS | 2ND9V3MN6O |
| PubChem | 53362096 |
| SureChEMBL | SCHEMBL1462843 |